Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
46 studies found for:    Pamidronate
Show Display Options
Rank Status Study
1 Completed Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver Transplant
Condition: Bone Disease, Metabolic
Interventions: Drug: Disodium pamidronate;   Drug: Placebo
2 Unknown  A Pilot Trial of Intravenous (IV) Pamidronate for Low Back Pain
Condition: Low Back Pain
Intervention: Drug: pamidronate
3 Completed A Pilot Trial of IV Pamidronate for Low Back Pain
Condition: Chronic Low Back Pain
Intervention: Drug: Pamidronate
4 Completed Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
Condition: Multiple Myeloma
Interventions: Drug: Pamidronate;   Drug: Thalidomide;   Drug: Zometa
5 Active, not recruiting Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial
Condition: Spondyloarthropathy
Interventions: Drug: golimumab;   Drug: Pamidronate
6 Completed Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma
Conditions: Refractory Multiple Myeloma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: pamidronate disodium;   Drug: arsenic trioxide;   Other: laboratory biomarker analysis;   Other: pharmacological study
7 Completed Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
Condition: Multiple Myeloma
Interventions: Drug: Pamidronate;   Drug: Thalidomide
8 Active, not recruiting The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Pamidronate;   Drug: Zoledronic acid;   Drug: placebo
9 Withdrawn Study of Pamidronate for the Prevention of Heterotopic Ossification
Condition: Heterotopic Ossification
Intervention: Drug: Pamidronate (AREDIA)
10 Completed Pamidronate Administration in Breast Cancer Patients With Bone Metastases
Conditions: Breast Cancer;   Neoplasm Metastasis
Intervention: Drug: Pamidronate
11 Completed The Use of Bisphosphonates in the Treatment of Avascular Necrosis of the Femoral Head
Condition: Femoral Head Avascular Necrosis
Intervention: Drug: Pamidronate Disodium
12 Recruiting Efficiency and Safety Study of Pamidronate in Inflammatory Back Pain Due to Degenerative Disk Disease
Conditions: Intervertebral Disc Degeneration;   Modic I Discopathy;   Back Pain;   Low Back Pain;   Magnetic Resonance Imaging (MRI)
Interventions: Drug: Pamidronate;   Other: Placebo
13 Completed Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation
Condition: Transplant Bone Disease
Interventions: Drug: Pamidronate;   Drug: vitamin D;   Drug: calcium supplement
14 Completed A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.
Condition: Bone Loss
Intervention: Drug: Pamidronate
15 Not yet recruiting Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease
Conditions: Solid Tumor;   Metastatic Bone Disease
Interventions: Biological: denosumab;   Drug: pamidronate
16 Not yet recruiting Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation
Conditions: Osteopenia;   Osteoporosis
Interventions: Drug: Pamidronate;   Drug: Calcium and vitamin D
17 Active, not recruiting Pamidronate to Treat Osteogenesis Imperfecta in Children
Condition: Osteogenesis Imperfecta
Intervention: Drug: Pamidronate (Aredia)
18 Completed Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention
Conditions: Osteopenia;   Complications of Heart-lung Transplant;   Other Complications of Lung Transplant
Intervention: Drug: zoledronic acid vs pamidronate
19 Unknown  Effect of Local Pamidronate in Preventing Bone Loss After Total Hip Arthroplasty
Conditions: Arthroplasty;   Mineral Density
Intervention: Drug: pamidronate
20 Active, not recruiting Combination Chemotherapy, Peripheral Stem Cell Transplantation, Biological Therapy, Pamidronate and Thalidomide in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Biological: filgrastim;   Biological: recombinant interferon alfa;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: melphalan;   Drug: pamidronate disodium;   Drug: thalidomide;   Procedure: peripheral blood stem cell transplantation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years